Latest Investor Relations News

Page 22 of 98
Riversgold Ltd has affirmed the material significance of its recent Northern Zone gold exploration results alongside a $2 million capital raising, assuring compliance with ASX continuous disclosure rules.
Maxwell Dee
Maxwell Dee
23 Jan 2026
Objective Corporation Limited has announced an on-market buy-back of up to 9.6 million ordinary shares, representing roughly 10% of its issued capital, set to run from February 2026 to February 2027.
Sophie Babbage
Sophie Babbage
23 Jan 2026
Codeifai Limited has responded to an ASX price query denying any undisclosed information behind recent unusual trading activity, while highlighting its nearing completion of the Antenna Transfer acquisition.
Sophie Babbage
Sophie Babbage
22 Jan 2026
BWP Group has updated its dividend announcement, confirming an estimated unfranked dividend of 9.58 cents per security for the half-year ending December 2025, alongside details of its dividend reinvestment plan pricing.
Victor Sage
Victor Sage
22 Jan 2026
BOA Resources has completed the issuance of securities tied to its $3.75 million placement after securing shareholder approval earlier this month.
Maxwell Dee
Maxwell Dee
22 Jan 2026
Bhagwan Marine Limited anticipates stable earnings and robust cash generation for the first half of FY26, underpinned by margin expansion and disciplined capital management.
Victor Sage
Victor Sage
22 Jan 2026
Miramar Resources has restructured its board, appointing Marion Bush as Managing Director and Jono Fisher as Non-Executive Chairman, aiming to drive growth and exploration success in Western Australia.
Maxwell Dee
Maxwell Dee
22 Jan 2026
Rivco Australia Limited has completed its internalisation, reporting a modest decline in net asset value alongside rising water spot prices and a strong dividend yield, signaling evolving dynamics in the water entitlements market.
Victor Sage
Victor Sage
21 Jan 2026
Australian Strategic Materials and Energy Fuels are set to discuss their proposed acquisition in a joint webcast, offering investors a closer look at this strategic move.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Cambium Bio has locked in a A$2.4 million strategic investment from Zheng Yang Biomedical Technology, reinforcing its push into pivotal Phase 3 trials for its dry eye disease treatment.
Ada Torres
Ada Torres
20 Jan 2026
Richmond Vanadium Technology Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity and attributing the surge to broader market interest and improved liquidity.
Maxwell Dee
Maxwell Dee
19 Jan 2026
Alice Queen Limited (AQX) has had its trading suspension lifted immediately following its response to an ASX Price Query, reopening access for investors.
Victor Sage
Victor Sage
19 Jan 2026